About T2 Biosystems
T2 Biosystems is a company based in Lexington (United States) founded in 2006.. T2 Biosystems has raised $454.3 million across 11 funding rounds from investors including Goldman Sachs, Canon and NIH. T2 Biosystems offers products and services including Diagnostic Products. T2 Biosystems operates in a competitive market with competitors including Inflammatix, Visby Medical, MeMed, GenMark Diagnostics and Molbio Diagnostics, among others.
- Headquarter Lexington, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name T2 Biosystems, Inc.
-
Annual Revenue
$7.19 M-67.75as on Dec 31, 2023
-
Net Profit
$-50.08 M19.23as on Dec 31, 2023
-
EBITDA
$-46.29 M10.58as on Dec 31, 2023
-
Total Equity Funding
$454.3 M (USD)
in 11 rounds
-
Latest Funding Round
$2 M (USD), Grant
Mar 06, 2018
-
Investors
Goldman Sachs
& 15 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of T2 Biosystems
T2 Biosystems is a publicly listed company on the OTC with ticker symbol TTOO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of T2 Biosystems
T2 Biosystems offers a comprehensive portfolio of products and services, including Diagnostic Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tools for in vitro testing in healthcare settings
Unlock access to complete
Unlock access to complete
Funding Insights of T2 Biosystems
T2 Biosystems has successfully raised a total of $454.3M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $2.0M
-
First Round
First Round
(01 Jan 2006)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2018 | Amount | Grant - T2 Biosystems | Valuation |
investors |
|
| Jan, 2017 | Amount | Debt – Conventional - T2 Biosystems | Valuation |
investors |
|
| Sep, 2016 | Amount | Post-IPO - T2 Biosystems | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in T2 Biosystems
T2 Biosystems has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Goldman Sachs, Canon and NIH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Founded Year | Domain | Location | |
|
Early-stage tech startups are funded by Flybridge Capital Partners.
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by T2 Biosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - T2 Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
T2 Biosystems Comparisons
Competitors of T2 Biosystems
T2 Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Visby Medical, MeMed, GenMark Diagnostics and Molbio Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on T2 Biosystems
Frequently Asked Questions about T2 Biosystems
When was T2 Biosystems founded?
T2 Biosystems was founded in 2006.
Where is T2 Biosystems located?
T2 Biosystems is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Who is the current CEO of T2 Biosystems?
John Sperzel is the current CEO of T2 Biosystems.
Is T2 Biosystems a funded company?
T2 Biosystems is a funded company, having raised a total of $454.3M across 11 funding rounds to date. The company's 1st funding round was a Post-IPO of $40M, raised on Jan 01, 2006.
What is the annual revenue of T2 Biosystems?
Annual revenue of T2 Biosystems is $7.19M as on Dec 31, 2023.
What does T2 Biosystems do?
T2 Biosystems was founded in 2006 in Lexington, United States, with operations centered in the biotechnology sector. Miniaturized magnetic resonance imaging platforms are developed for clinical diagnostics. Pathogens are detected using the proprietary T2MR technology, which measures alterations in water molecule reactions within magnetic fields. Diagnostic panels targeting bacterial septic infections, hemostasis, and Lyme disease are under development.
Who are the top competitors of T2 Biosystems?
T2 Biosystems's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does T2 Biosystems offer?
T2 Biosystems offers Diagnostic Products.
Is T2 Biosystems publicly traded?
Yes, T2 Biosystems is publicly traded on OTC under the ticker symbol TTOO.
Who are T2 Biosystems's investors?
T2 Biosystems has 16 investors. Key investors include Goldman Sachs, Canon, NIH, Flagship Pioneering, and DOE.
What is T2 Biosystems's ticker symbol?
The ticker symbol of T2 Biosystems is TTOO on OTC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.